BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $15,011,588 | – | 333,665 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 380,012 | $42,618,000 | 8.86% |
DAFNA Capital Management LLC | 206,911 | $23,205,000 | 6.90% |
Casdin Capital, LLC | 1,550,000 | $173,833,000 | 5.15% |
Eagle Health Investments LP | 62,060 | $6,960,000 | 4.45% |
SIB LLC | 54,912 | $6,158,000 | 4.11% |
CADIAN CAPITAL MANAGEMENT, LP | 1,059,450 | $118,817,000 | 3.05% |
Tri Locum Partners LP | 73,906 | $8,289,000 | 3.01% |
Integral Health Asset Management, LLC | 85,000 | $9,533,000 | 2.84% |
MAKENA CAPITAL MANAGEMENT LLC | 38,924 | $4,365,000 | 2.42% |
Rock Springs Capital Management LP | 842,000 | $94,430,000 | 2.00% |